The Sentencing Project, “Fact Sheet: Trends in U.S. Corrections,” June 26, 2017, available at <https://www.sentencing-project.org/publications/trends-in-u-s-corrections/> (last visited April 6, 2018).+(last+visited+April+6,+2018).>Google Scholar

Ingraham, C., “CDC Releases Grim New Opioid Overdose Figures: ‘We’re Talking about More than an Exponential Increase,’” Washington Post, December 21, 2017, available at <https://www.washingtonpost.com/news/wonk/wp/2017/12/21/cdc-releases-grim-new-opioid-overdose-figures-were-talking-about-more-than-an-exponential-increase/?utm_term=.607955741560> (last visited April 6, 2018).+(last+visited+April+6,+2018).>Google Scholar

Bronson, J. et al., Bureau of Justice Statistics, Drug Use, Dependence, and Abuse Among State Prisoners and Jail Inmates, 2007-2009, NCJ 250546 (June 2017).Google Scholar

See Section III. infra.Google Scholar

American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, 5th ed. (Arlington, VA: American Psychiatric Association Publishing, 2013).Google Scholar

Williams, T., “Opioid Users Are Filling Jails. Why Don’t Jails Treat Them?” New York Times, August 4, 2017, available at <https://www.nytimes.com/2017/08/04/us/heroin-addiction-jails-methadone-suboxone-treatment.html> (last visited April 6, 2018).+(last+visited+April+6,+2018).>Google Scholar

Center for Substance Abuse Treatment, Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs, Treatment Improvement Protocol Series 43 (Revised 2012).Google Scholar

Park, T.W. and Friedmann, P.D., “Medication for Addiction Treatment: An Opportunity for Prescribing Clinicians to Facilitates Remission from Alcohol and Opioid Use Disorders,” Rhode Island Medical Journal 97, no. 10 (2014): 20-24, at 22-23.Google Scholar

Williams, supra note 6; see also Friedmann, P.D. et al., “Medication-Assisted Treatment in Criminal Justice Agencies Affiliated with the Criminal Justice-Drug Abuse Treatment Studies (CJ-DATS): Availability, Barriers & Intentions,” Substance Abuse 33 (2012): 9-18, at 12; A. Nunn et al., “Metha-done and Buprenorphine Prescribing and Referral Practices in US Prison Systems: Results from a Nationwide Survey,” Drug and Alcohol Dependence 105 (2009): 83-88, at 84-85; B. Schwartzapfel, “A Better Way to Treat Addiction in Jail,” The Marshall Project, March 1, 2017, available at <https://www.themarshallproject.org/2017/03/01/a-better-way-to-treat-addiction-in-jail> (last visited April 6, 2018).CrossRefGoogle Scholar

Chandler, R.K. et al., “Treating Drug Abuse and Addiction in the Criminal Justice System: Improving Public Health and Safety,” JAMA 301 (2009): 183-190, at 185.Google Scholar

Greene, T. et al., “Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System,” JAMA Psychiatry (February 14, 2018): E1-E3, at E1, available at <https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2671411> (last visited April 6, 2018).+(last+visited+April+6,+2018).>Google Scholar

See Section IV.Google Scholar

For an excellent overview of the topic, see Lebowitz, D., “‘Proper Subjects for Medical Treatment?’ Addiction, Prison-Based Drug Treatment, and the Eighth Amendment,” DePaul Journal of Healthcare Law 14, no. 2 (2012): 271-308.Google Scholar

.S. Constitution, amendment VIII.Google Scholar

Estelle v. Gamble, 429 U.S. 97, 103 (1976).Google Scholar

Id., at 99.Google Scholar

Id., at 100.Google Scholar

Id.Google Scholar

Id., at 100-01.Google Scholar

Id., at 104.Google Scholar

Id.Google Scholar

Id., at 105.Google Scholar

Id., at 106Google Scholar

Madrid v. Gomez, 889 F. Supp. 1146, 1210 (N.D. Cal. 1995).Google Scholar

Id., at 1215.Google Scholar

Coleman v. Wilson, 912 F. Supp. 1282, 1316, 1319 (E.D. Cal. 1995).Google Scholar

Brown v. Plata, 563 U.S. 493, 500 (2011).Google Scholar

Id. at 502.Google Scholar

Plata, 563 U.S. at 511.Google Scholar

Wellman v. Faulkner, 715 F.2d 269, 272 (7th Cir. 1983) (internal citations omitted).Google Scholar

Braggs v. Dunn, 257 F. Supp. 3d 1171, 1267 (M.D. Ala. 2017).Google Scholar

Dunn v. Dunn, 219 F. Supp. 3d 1100, 1123 (M.D. Ala. 2016).Google Scholar

See e.g., Postawko v. Mo. Dep’t Corr., 2017 U.S. Dist. LEXIS 117238, at *51 (W.D. Mo.); Lipert v. Baldwin, 2017 U.S. Dist. LEXIS 64687, at *28 (N.D. Ill.).Google Scholar

Hoffer v. Jones, 2017 U.S. Dist. LEXIS 194544, at *6 (N.D. Fla.).Google Scholar

Wilson v. Seiter, 501 U.S. 294, 300 (1991).Google Scholar

Farmer v. Brennan, 511 U.S. 825, 847 (1994).Google Scholar

Seiter, 501 U.S. at 297.Google Scholar

Farmer, 511 U.S. at 836, 839-40.Google Scholar

Id., at 842.Google Scholar

Baez v. Rogers, 522 Fed. Appx. 819, 821 (11th Cir. 2013) (citing McElligott v. Foley, 182 F.3d 1248, 1255 (11th Cir. 1999)).Google Scholar

Farmer, 511 U.S. at 844.Google Scholar

Jones v. Bradshaw, 2017 U.S. Dist. LEXIS 46829, at *26-27 (S.D. Fla.).Google Scholar

Bowring v. Godwin, 551 F.2d 44, 48 (4th Cir. 1977).Google Scholar

Tarver v. McLaughlin, 2017 U.S. Dist. LEXIS 129737, at *12 (M.D. Ga.).Google Scholar

Corley v. Wexford Health Sources, Inc., 2016 U.S. Dist. LEXIS 122306, at *31 (S.D. Ill.).Google Scholar

Knop v. Johnson, 667 F.Supp. 512, 528 (W.D. Mich. 1987).Google Scholar

Prosser v. Nagaldinne, 927 F. Supp. 2d 708, 728 (E.D. Mo. 2013).Google Scholar

King v. Kramer, 680 F.3d 1013, 1019 (7th Cir. 2012).Google Scholar

McGiboney v. CCA Western Props., 2016 U.S. Dist. LEXIS 27491, at *23-24 (D. Idaho).Google Scholar

Hoptowit v. Ray, 682 F.2d 1237, 1253 (9th Cir. 1982).Google Scholar

Waldrop v. Evans, 871 F.2d 1030, 1035 (11th Cir. 1989).Google Scholar

United States v. DeCologero, 821 F.2d 39, 43 (1st Cir. 1987).CrossRefGoogle Scholar

Nauroth v. Southern Health Partners, Inc., 2009 U.S. Dist. LEXIS *86467, at *33 (S.D. Ohio).Google Scholar

Butler v. City of Pontiac, 2006 U.S. Dist. LEXIS 55845, at *18 (E.D. Mich.).Google Scholar

Harris v. Thigpen, 941 F.2d 1495, 1509 (11th Cir. 1991).Google Scholar

Dunn v. Dunn, 219 F. Supp. 3d at 1130.Google Scholar

Estelle, 429 U.S. at 104.Google Scholar

Helling v. McKinney, 509 U.S. 25, 27-28 (1993).Google Scholar

McKinney v. Anderson, 924 F.2d 1500, 1505-09 (9th Cir. 1991), vacated, 502 U.S. 903 (1991).Google Scholar

Helling, 509 U.S. at 30, 33.Google Scholar

Id., at 33.Google Scholar

Id., at 36.Google Scholar

See Wakefield v. Thomas, 777 F.3d 1160 (9th Cir. 1999); Lugo v. Senkowski, 114 F. Supp. 2d 111 (N.D.N.Y. 2000).Google Scholar

Gaudreault v. Municipality of Salem, Mass., 923 F.2d 203, 208 (1st Cir. 1990) (citing Laaman v, Helgemoe, 437 F. Supp. 269, 311(D.N.H. 1977)); Monmouth Cnty. Corr. Institutional Inmates v. Lanzaro, 834 F.2d 326, 347 (3d Cir. 1987); Gutierrez v. Peters, 111 F.3d 1364, 1373 (7th Cir. 1997); Sheldon v. Pezley, 49 F.3d 1312, 1316 (8th Cir. 1995); Ramos v. Lamm, 639 F.2d 559, 575 (10th Cir. 1980); Hill v. Dekalb Reg’l Youth Det. Ctr., 40 F.3d 1176, 1187 (11th Cir. 1994).Google Scholar

Brock v. Wright, 315 F.3d 158, 162 (2d Cir. 2003) (quoting Chance v. Armstrong, 143 F.3d 698, 702 (2d Cir. 1998)). See also McGuckin v. Smith, 974 F.2d 1050, 1059-60 (9th Cir. 1992), overruled in part on other grounds by WMX Techs., Inc. v. Miller, 104 F.3d 1133, 1135 (9th Cir. 1997).Google Scholar

W.J. Rold, “Thirty Years After Estelle v. Gamble: A Legal Retrospective,” Journal of Correctional Health Care 14 (2008): 11-20, at 16.Google Scholar

Davis v. Carter, 452 F.3d 686, 689-90 (7th Cir. 2006); Demouchette v. Dart, 2015 U.S. Dist. LEXIS 18582, at *11 (N.D. Ill.); Idyle v. N.C. Dep’t of Corr. Med. Dep’t, 2014 U.S. Dist. LEXIS 13765, at *6 (E.D.N.C.); Meiller v. Pasco County, 2010 U.S. Dist. LEXIS 140523, at *26-27 (M.D. Fla.); Alvarado v. Westchester County, 22 F. Supp. 3d 208, 217 (S.D.N.Y. 2014); Sylvester v. City of Newark, 120 Fed. Appx. 419, 423 (3d Cir. 2005); Quatroy v. Jefferson Parish Sheriff ’s Office, 2009 U.S. Dist. LEXIS 40807, at *27-28 (E.D. L.A.); Gonzalez v. Cecil County, 221 F. Supp. 2d 611, 616 (D. Md. 2002); Butler, 2006 U.S. Dist. LEXIS 55845 at *17-18.Google Scholar

See e.g., Iacovangelo v. Corr. Med. Care, Inc., 624 Fed. Appx. 10, 13 (2d Cir. 2015); Shaver v. Brimfield Twp., 2014 U.S. Dist. LEXIS 180571, at *41 (N.D. Ohio).Google Scholar

United States ex rel. Walker v. Fayette County, 599 F.2d 573, 576 (3d Cir. 1979).Google Scholar

Demouchette, 2015 U.S. Dist. LEXIS 18582 at *13.Google Scholar

Quatroy, 2009 U.S. Dist. LEXIS 40807 at *5.Google Scholar

Messina v. Mazzeo, 854 F. Supp. 116, 140 (E.D.N.Y. 1994).Google Scholar

Helling, 509 U.S. at 36.Google Scholar

Volkow, N.D., National Institute on Drug Abuse, Drugs, Brains, and Behavior: The Science of Addiction, NIH Pub. No. 14-5605 (revised July 2014): at 5.Google Scholar

Hasin, D.S. et al., “DSM-5 Criteria for Substance Use Disorders: Recommendations and Rationale,” American Journal of Psychiatry 170 (2013): 835-851, at 836.Google Scholar

Jessell, L. et al., “Sexual Violence in the Context of Drug Use Among Young Adult Opioid Users in New York City,” Journal of Interpersonal Violence 32 (2015): 2929-2954, at 2931.Google Scholar

Brooner, R.K. et al., “Psychiatric and Substance use Comorbidity Among Treatment-Seeking Opioid Abusers,” Archives of General Psychiatry 54 (1997): 71-80, at 74.Google Scholar

Winklbaur, B. et al., “Treating Pregnant Women Dependent on Opioids is not the Same as Treating Pregnancy and Opioid Dependence: A Knowledge Synthesis for Better Treatment for Women and Neonates,” Addiction 103 (2008): 1429-1440, at 1429-30.Google Scholar

Ronan, M.V. et al., “Hospitalizations Related to Opioid Abuse/Dependence and Associated Serious Infections from 2002 to 2012,” Health Affairs 35 (2016): 832-837, at 836.Google Scholar

Teesson, et al., “Long-Term Mortality, Remission, Criminality and Psychiatric Comorbidity of Heroin Dependence: 11-year Findings from the Australian Treatment Outcome Study,” Addiction 110 (2015): 986-993, at 991.Google Scholar

Schuckit, M.A., “Treatment of Opioid Use Disorders,” N. Engl. J. Med. 375 (2016): 357-268, at 357.Google Scholar

Connock, M. et al., “Methadone and Buprenorphine for the Management of Opioid Dependence: A Systematic Review and Economic Evaluation,” Health Technology Assessment 11, no. 9 (2007): 1-6, at 3.Google Scholar

Moore, B.A. et al., “Primary Care Office-Based Buprenorphine Treatment: Comparison of Heroin and Prescription Opioid Dependent Patients,” Journal of General Internal Medicine 22 (2007): 527-30.Google Scholar

Weiss, R.D. et al., “Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid Dependence,” Archives of General Psychiatry 68, (2011): 1238-46, at 1243.Google Scholar

Id.Google Scholar

See e.g., Farré, M. et al., “Retention Rate and Illicit Opioid use During Methadone Maintenance Interventions: A Meta-Analysis,” Drug and Alcohol Dependence 65 (2002): 283-290, at 286.Google Scholar

See e.g., Woody, G.E. et al., “Extended vs. Short-Term Buprenorphine-Naloxone for Treatment of Opioid-Addicted Youth: A Randomized Trial,” JAMA 300 (2008): 2003-2011; D.A. Fiellin et al., “Counseling plus Buprenorphine–Naloxone Maintenance Therapy for Opioid Dependence” NEJM 355 (2006): 365-374; L.A. Marsch, “The Efficacy of Methadone Maintenance Interventions in Reducing Illicit Opiate Use, HIV Risk Behavior and Criminality: A Meta-Analysis,” Addiction 93 (1998): 515-532, at 515.CrossRefGoogle Scholar

Raleigh, M.F., “Buprenorphine Maintenance vs. Placebo for Opioid Dependence, American Family Physician 95 (2017): 290-291, at 290.Google ScholarPubMed

Arroll, B. et al., “Efficacy and Tolerability of Tricyclic Antidepressants and SSRIs Compared With Placebo for Treatment of Depression in Primary Care: A Meta-Analysis,” Annals of Family Medicine 3 (2005): 449-456, at 449.Google Scholar

Jonas, D.E. et al., “Pharmacotherapy for Adults with Alcohol use Disorders in Outpatient Settings: A Systematic Review and Meta-Analysis,” JAMA 311 (2014): 1889-1900, at 1892.Google Scholar

Kooy, A. et al., “Long-term Effects of Metformin on Metabolism and Microvascular and Macrovascular Disease in Patients With Type 2 Diabetes Mellitus,” Archives of Internal Medicine 169 (2009): 615-626, at 620; J.J. Mourad et al., “Number Needed to Treat and Reduction of Outcomes with RAAS Inhibitors,” European Heart Journal 34 (2013): 1117-1118, at 1117.Google Scholar

Lee, J.D. et al., “Opioid Treatment at Release from Jail using Extended Release Naltrexone: A Pilot Proof-of-Concept Randomized Effectiveness Trial,” Addiction 110 (2015): 1008-1014, at 1009.Google Scholar

Kunøe, N. et al, “Design of a Randomized Controlled Trial of Extended-Release Naltrexone Versus Daily Buprenorphine-Naloxone for Opioid Dependence in Norway (NTX-SBX)” BMC Pharmacology & Toxicology 17, no. 18 (2016): 1-10.Google Scholar

Cousins, S.J. et al., “Predictors of Continued Use of Extended-Released Naltrexone (XR-NTX) for Opioid-Dependence: An Analysis of Heroin and Non-Heroin Opioid Users in Los Angeles County,” Journal of Substance Abuse Treatment 63 (2016): 66-71.Google Scholar

Bronson, supra note 3.Google Scholar

Westerberg, V.S. et al., “Community-Based Methadone Maintenance in a Large Detention Center is Associated with Decreases in Inmate Recidivism,” Journal of Substance Abuse Treatment 70 (2016): 1-6, at 1.Google Scholar

Clarke, J.G. et al., “Active and Former Injection Drug Users Report of HIV Risk Behaviors During periods of Incarceration,” Substance Abuse 22 (2001): 209-216, at 213.Google Scholar

See note 9, supra.Google Scholar

Schuckit, supra note 81, at 357.Google Scholar

Noonan, M.E., Bureau of Justice Statistics, Mortality in Local Jails, 2000-2014 – Statistical Tables, NCJ 250169 (December 2016): 6; Pamela Lehman, “Jail Staff Trained to Use Narcan to Prevent Opioid Overdoses,” Morning Call, September 18, 2017, available at <http://www.mcall.com/news/breaking/mc-nws-narcan-jails-20170811-story.html> (last visited April 6, 2018).+(last+visited+April+6,+2018).>Google Scholar

Noonan, supra note 100, at 6.Google Scholar

Noonan, M.E., Bureau of Justice Statistics, Mortality in States Prisons, 2001-2014 – Statistical Tables, NCJ 250150 (December 2016): 5.Google Scholar

See e.g., Johnson, S., “State Officials Calls Prevalence of Drugs in Prisons, Regional Jails ‘Disgraceful,” MetroNews, March 16, 2017, available at <http://wvmetronews.com/2017/03/16/state-official-calls-prevalence-of-drugs-in-prisons-regional-jails-disgraceful> (last visited April 6, 2018); Associated Press, “California Inmates Dying of Drug Overdoses at Rate Nearly Triple the National Average,” Fox News, June 21, 2015, available at <http://www.foxnews.com/us/2015/06/21/california-inmates-die-drug-overdoses-at-rate-nearly-triple-national-average.html> (last visited April 6, 2018); J. Hernandez, “Recent Overdoses Highlight the Difficulty of Keeping Drugs out of Jail,” WHYY, Oct. 16, 2017, available at <https://whyy.org/articles/recent-south-jersey-overdoses-highlight-difficulty-keeping-drugs-jails> (last visited April 6, 2018); S. Houser, “Marion County Sheriff’s Office Warns of Increase in Drug Overdoses Inside Jail,” Fox 59, Aug. 30, 2017, available at <http://fox59.com/2017/08/30/marion-county-sheriffs-office-warns-of-increase-in-drug-overdoses-inside-jail> (last visited April 6, 2018).+(last+visited+April+6,+2018);+Associated+Press,+“California+Inmates+Dying+of+Drug+Overdoses+at+Rate+Nearly+Triple+the+National+Average,”+Fox+News,+June+21,+2015,+available+at++(last+visited+April+6,+2018);+J.+Hernandez,+“Recent+Overdoses+Highlight+the+Difficulty+of+Keeping+Drugs+out+of+Jail,”+WHYY,+Oct.+16,+2017,+available+at++(last+visited+April+6,+2018);+S.+Houser,+“Marion+County+Sheriff’s+Office+Warns+of+Increase+in+Drug+Overdoses+Inside+Jail,”+Fox+59,+Aug.+30,+2017,+available+at++(last+visited+April+6,+2018).>Google Scholar

Centers for Disease Control and Prevention, National Center for Health Statistics, “Underlying Cause of Death 1999-2016 on CDC WONDER Online Database,” released December, 2017, available at <http://wonder.cdc.gov/ucd-icd10.html> (last visited April 6, 2018).+(last+visited+April+6,+2018).>Google Scholar

Merrall, E.L.C. et al., “Meta-Analysis of Drug-Related Deaths Soon after Release from Prison,” Addiction 105 (2010): 1545-1554, at 1549.Google Scholar

Id.Google Scholar

Binswanger, I.A. et al., “Mortality After Prison Release: Opioid Overdose and Other Causes of Death, Risk Factors, and Time Trends from 1999-2009,” Annals of Internal Medicine 159 (2013): 592-600, at 597.Google Scholar

Rich, J.D. et al., “Methadone Continuation Versus Forced Withdrawal on Incarceration in a Combined US Prison and Jail: A Randomized, Open-Label Trial,” Lancet 386 (2015): 350-59, at 351-52, 355-56.Google Scholar

Gisev, N. et al., “Determining the Impact of Opioid Substitution Therapy upon Mortality and Recidivism among Prisoners: A 22 Year Data Linkage Study,” Technical Report no. 330 (2014): 34.Google Scholar

Marsden, J. et al., “Does Exposure to Opioid Substitution Treatment in Prison Reduce the Risk of Death after Release? A National Prospective Observational Study in England,” Addiction 112 (2017): 1408-1418, at 1415.Google Scholar

Clarke et al., supra note 97, at 216.Google Scholar

Helling, 509 U.S. at 33.Google Scholar

Plata, 563 U.S. at 509, 531-32.Google Scholar

Beckman, A.L. et al., “New Hepatitis C Drugs Are Very Costly And Unavailable to Many State Prisoners,” Health Affairs 35 (2016): 1893-1901, at 1893.; K. Stark et al., “History of Syringe Sharing in Prison, and Risk of Hepatitis B Virus, Hepatitis C Virus, and Human Immunodeficiency Virus Infection among Injecting Drug Users in Berlin,” International Journal of Epidemiology 26 (1997): 1359-1366, at 1363.Google Scholar

Beckman et al., supra note 114, at 1893.Google Scholar

Scutti, S., “New Hepatitis C Infections Triple Due to Opioid Epidemic,” CNN, May 11, 2017, available at <http://www.cnn.com/2017/05/11/health/hepatitis-c-rates-cdc-study/index.html> (last visited April 6, 2018).+(last+visited+April+6,+2018).>Google Scholar

Beckman, supra note 114, at 1893.Google Scholar

Bretaña, N.A. et al., “Transmission of Hepatitis C Virus among Prisoners, Australia, 2005-2012,” Emerging Infections Diseases 21 (2015): 765-774, at 770.Google Scholar

Springer, S.A. et al., “Improved HIV and Substance Abuse Treatment Outcomes for Released HIV-Infected Prisoners: The Impact of Buprenorphine Treatment,” Journal of Urban Health 87 (2010): 592-602, at 592, 598.Google Scholar

Dolan, K. et al., “People who Inject Drugs in Prison: HIV Prevalence, Transmission and Prevention,” International Journal of Drug Policy 26 (2015): 512-515, at 513.Google Scholar

Helling, 509 U.S. at 35.Google Scholar

Fullerton, et al., “Medication-Assisted Treatment With Metha-done: Assessing the Evidence,” Psychiatric Services 65 (2014): 146-157, at 153.Google Scholar

Marsch, supra note 87, at 515.Google Scholar

Gowing, L. et al., “Substitution Treatment of Injecting Opioid Users for Prevention of HIV Infection,” Cochrane Database of Systematic Reviews 2 (2008): 1-52, at 15-16.Google Scholar

Dolan, K.A. et al., “Four-Year Follow-Up of Imprisoned Male Heroin Users and Methadone Treatment: Mortality, Re-Incarceration and Hepatitis C Infection,” Addiction 100 (2005): 820-28, at 824.Google Scholar

Beckman, supra note 114, at 1899.Google Scholar

Goodnough, A. and Zernike, K., “Seizing on Opioid Crisis, a Drug Maker Lobbies Hard for Its Product,” New York Times, June 11, 2017, available at <https://www.nytimes.com/2017/06/11/health/vivitrol-drug-opioid-addiction.html> (last visited April 6, 2018).+(last+visited+April+6,+2018).>Google Scholar

Substance Abuse and Mental Health Services Administration, State Targeted Response to the Opioid Crisis Grants, T1-17-014, available at <https://www.samhsa.gov/sites/default/files/grants/pdf/other/ti-17-014-opioid-str-abstracts.pdf> (last visited April 6, 2018)..+(last+visited+April+6,+2018)..>Google Scholar

Substance Abuse and Mental Health Services Administration, “Certification of Opioid Treatment Programs,” available at <https://www.samhsa.gov/medication-assisted-treatment/opioid-treatment-programs> (last visited April 6, 2018).+(last+visited+April+6,+2018).>Google Scholar

Monmouth County Correctional Institutional Inmates v. Lanzaro, 834 F.2d 326 (3d Cir. 1987).Google Scholar

Jones, H.E., “Practical Considerations for the Clinical Use of Buprenorphine,” Science and Practice Perspectives 2, no. 2 (2004): 4-20, at 9.Google Scholar

Reynaud, M. et al., “Six Deaths Linked to Concomitant use of Buprenorphine and Benzodiazepines,” Addiction 93 (1998): 1385-1392, at 1389.Google Scholar

Lavender, G., “California Prisons Aim to Keep Sex Between Inmates Safe, If Illegal,” NPR, January 21, 2015, available at <https://www.npr.org/2015/01/21/378678167/california-prisons-aim-to-keep-sex-between-inmates-safe-if-illegal> (last visited April 6, 2018).+(last+visited+April+6,+2018).>Google Scholar

Lebowitz, supra note 13, at 297 n.144.Google Scholar

Brown, 563 U.S. at 511.Google Scholar

Nunn et al., supra note 9, at 86.Google Scholar

Dunn v. Dunn, 219 F. Supp. 3d at 1127. See also Baez, 522 F. Appx. at 821.Google Scholar

Sain v. Wood, 512 F.3d 886, 895 (7th Cir. 2008).Google Scholar

Inmates of Allegheny County Jail v. Pierce, 612 F.2d 754, 762 (3rd Cir. 1979)Google Scholar

Hoptowit, 682 F.2d at 1253.Google Scholar

Id.Google Scholar

Harris, 941 F.2d at 1509.Google Scholar

Hoffer 2017 U.S. Dist. LEXIS 194544, at *6.Google Scholar

Harris, 941 F.2d at 1509.Google Scholar

Donaher, P.A. and Welsh, C., “Managing Opioid Addiction with Buprenorphine,” American Family Physician 73 (2006): 1573-1578, at 1577.Google Scholar

Rich, J.D. et al., “Linkage with Methadone Treatment Upon Release from Incarceration,” Journal of Addictive Diseases 24 (2005): 49-59, at 56.Google Scholar

Magura, S. et al., “Buprenorphine and Methadone Maintenance in Jail and Post-Release: A Randomized Clinical Trial,” Drug and Alcohol Dependence 99 (2009): 222-230, at 227.Google Scholar

Id. at 228.Google Scholar

Gordon, M.S. et al., “A Randomized Controlled Trial of Prison-Initiated Buprenorphine: Prison Outcomes and Community Treatment Entry,” Drug and Alcohol Dependence 142 (2014): 33-40, at 38.Google Scholar

Lin, J.T. and Matthew, P., “Cancer Pain Management in Prisons: A Survey of Primary Care Practitioners and Inmates,” Journal of Pain and Symptom Management 29 (2005): 466-473, at 471-472.Google Scholar

Freyer, F., “R.I. Prison Takes a Leap into Comprehensive Addiction Care,” The Boston Globe, August 14, 2017, available at <https://www.bostonglobe.com/metro/2017/08/13/prison-takes-leap-into-comprehensive-addiction-care/K3lxG2FPWsI7mmwqMOSXxN/story.html> (last visited April 6, 2018); K.F. Maurer, “Opioid Addiction and Corrections: Medication Assisted Treatment in the Connecticut Department of Correction,” April 30, 2015, available at <http://www.ct.gov/opm/lib/opm/cjppd/cjcjpac/20150430_cjpacpowerpoint_-metha-done_presentation.pdf> (last visited April 6, 2018).+(last+visited+April+6,+2018);+K.F.+Maurer,+“Opioid+Addiction+and+Corrections:+Medication+Assisted+Treatment+in+the+Connecticut+Department+of+Correction,”+April+30,+2015,+available+at++(last+visited+April+6,+2018).>Google Scholar

Farabee, D. et al., “Treatment in Criminal Justice Settings,” in el-Guebaly, N. et al., eds., Textbook of Addiction Treatment: International Perspectives (Milano: Springer-Verlag Mailand, 2015): 1129-1144, at 1134-1135.Google Scholar

Weiss et al., supra note 84, at 1244.Google Scholar

Fiellin et al., supra note 87, at 371; Schwartz, R.P. et al., “Randomized Trial of Standard Methadone Treatment Compared to Initiating Methadone without Counseling: 12-month Findings,” Addiction 107 (2012): 943-952, at 950.Google Scholar

Friedmann, P.D. and Schwartz, R.P., “Just Call it ‘Treatment,’” Addiction Science & Clinical Practice 7, no. 10 (2012): 1-3, at 2.Google Scholar

Helling, 509 U.S. at 36.Google Scholar

Rhodes v. Champan, 452 U.S. 337, 346 (1981) (quoting Trop v. Dulles, 356 U.S. 86, 101 (1958) (plurality opinion)).Google Scholar

D. Lebowitz, supra note 13, at 297-298.Google Scholar

Dunn, 219 F. Supp. 3d at 1128 n.37.Google Scholar

See Smith, D.E., “The Evolution of Addiction Medicine as a Medical Specialty,” American Medical Association Journal of Ethics 13 (2011): 900-905, at 902-903.Google Scholar

World Health Organization, “Principles of Drug Dependence Treatment,” (March 2008), available at <http://www.who.int/substance_abuse/publications/principles_drug_dependence_treatment.pdf>(last visited April 6, 2018).(last+visited+April+6,+2018).>Google Scholar

National Institute of Drug Abuse, Principles of Drug Addiction Treatment, Pub. No 12-4180 (revised December 2012).Google Scholar

Center for Substance Abuse Treatment, supra note 7.Google Scholar

Center for Disease Control, “Treat Opioid Use Disorder”, available at <https://www.cdc.gov/drugoverdose/prevention/treatment.html> (last visited April 6, 2018).+(last+visited+April+6,+2018).>Google Scholar

Combating the Opioid Abuse Epidemic: Professional and Academic Perspectives: Hearing Before the H. Comm. on Energy and Commerce, 114th Cong. (2015) (Statement of the American Medical Association).Google Scholar

American Academy of Pediatrics Committee on Substance Use and Prevention, “Medication-Assisted Treatment of Adolescents With Opioid Use Disorders,” ISSN 1098-4275 (August 2016), available at <http://pediatrics.aappublications.org/content/pediatrics/early/2016/08/18/peds.2016-1893.full.pdf> (last visited April 6, 2018).+(last+visited+April+6,+2018).>Google Scholar

World Health Organization, supra note 161.Google Scholar

American Psychiatric Association, “Position Statement on Treatment of Substance Use Disorders in the Criminal Justice System” (December 2016).Google Scholar

Malave, E., “Note: Prison Health Care After the Affordable Care Act: Envisioning an End to the Policy of Neglect,” New York University Law Review 89 (2014): 700-738, at 730.Google Scholar

Id. at 731.Google Scholar

Kaiser Family Foundation, “States Reporting Medicaid coverage of Medication Assisted Treatment (MAT) Drugs,” 2017, available at <https://www.kff.org/medicaid/state-indicator/states-reporting-medicaid-coverage-of-medication-assisted-treatment-mat-drugs/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D> (last visited June 4, 2018).+(last+visited+June+4,+2018).>Google Scholar

Volkow, et al., “Medication-Assisted Therapies – Tackling the Opioid-Overdose Epidemic,” New England Journal of Medicine 370 (2014): 2063-2066, at 2065.CrossRefGoogle Scholar

Clemans-Cope, L. et al., “Medicaid Coverage of Effective Treatment for Opioid Use Disorder,” Urban Institute, June 2017, available at <https://www.urban.org/sites/default/files/publication/90461/2001287_medicaid_coverage_of_effective_treatment_for_opioid_use_disorder.pdf> (last visited April 6, 2018).+(last+visited+April+6,+2018).>Google Scholar

Id.Google Scholar

Merica, D., “Trump Declares Opioid Epidemic a National Health Emergency,” CNN, October 26, 2017, available at <http://www.cnn.com/2017/10/26/politics/donald-trump-opioid-epidemic/index.html> (last visited June 4, 2018).+(last+visited+June+4,+2018).>Google Scholar

President’s Commission on Combating Drug Addiction and the Opioid Crisis, Final Report, Nov 1. 2017: 32, available at <https://www.whitehouse.gov/sites/whitehouse.gov/files/images/Final_Report_Draft_11-1-2017.pdf> (last visited April 6, 2018).+(last+visited+April+6,+2018).>Google Scholar

United States Department of Health and Human Services, Office of the Surgeon General, Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health, (November 2016).Google Scholar

National Governor’s Association, “A Compact to Fight Opioid Addiction,” (July 13, 2016), available at <https://www.nga.org/cms/news/2016/opioid-compact> (last visited April 6, 2018).+(last+visited+April+6,+2018).>Google Scholar

National Association of Drug Court Professionals, “Resolution of the Board of Directors on the Availability of Medically Asissted Treatment (M.A.T) for Addiction in Drug Courts,” available at <https://www.nadcp.org/sites/default/files/nadcp/NADCP%20Board%20Statement%20on%20MAT.pdf> (last visited April 6, 2018); See also B. Andraka-Chris-tou, “What Is ‘Treatment’ for Opioid Addiction in Problem-Solving Courts? A Study of 20 Indiana Drug and Veterans Courts,” Stanford Journal of Civil Rights and Civil Liberties 13, (2017): 189-254, at 240.+(last+visited+April+6,+2018);+See+also+B.+Andraka-Chris-tou,+“What+Is+‘Treatment’+for+Opioid+Addiction+in+Problem-Solving+Courts?+A+Study+of+20+Indiana+Drug+and+Veterans+Courts,”+Stanford+Journal+of+Civil+Rights+and+Civil+Liberties+13,+(2017):+189-254,+at+240.>Google Scholar

Lopez, G., “There’s a Highly Successful Treatment for Opioid Addiction. But Stigma is Holding it Back,” Vox, November 15, 2017, available at <https://www.vox.com/science-and-health/2017/7/20/15937896/medication-assisted-treatment-methadone-buprenorphine-naltrexone> (last visited April 9, 2018).+(last+visited+April+9,+2018).>Google Scholar

Donnelly, G., “As Drug Overdoses Hit Record High, Trump Offers Little on Opioid Policy,” Fortune, August 8, 2017, available at <http://fortune.com/2017/08/08/record-high-drug-related-death-rate-2016/> (last visited April 9, 2018).+(last+visited+April+9,+2018).>Google Scholar

Vestal, C., “At Rikers Island, a Legacy of Medication-Assisted Opioid Treatment,” Stateline, May 23, 2016, available at <http://www.pewtrusts.org/en/research-and-analysis/blogs/stateline/2016/05/23/at-rikers-island-a-legacy-of-medication-assisted-opioid-treatment> (last visited April 9, 2018).+(last+visited+April+9,+2018).>Google Scholar

Chen, H. and Menard, L., “Medication-Assisted Treatment for Inmates: Work Group Evaluation Report and Recommendations,” Report to the Vermont Legislature (November 16, 2016), available at <https://legislature.vermont.gov/assets/Legislative-Reports/DOC-MAT-Eval-report-final.pdf> (last visited April 9, 2018); Maurer, supra note 151.+(last+visited+April+9,+2018);+Maurer,+supra+note+151.>Google Scholar

Freyer, F., “State Crime Bills would Expand Inmates’ Access to Addiction Treatment,” The Boston Globe, November 20, 2017, available at <https://www.bostonglobe.com/metro/2017/11/20/state-crime-bills-would-expand-inmates-access-addiction-treatment/7TI2SCOz5FNEZgmrEnIl2O/story.html> (last visited April 9, 2018).+(last+visited+April+9,+2018).>Google Scholar

Bureau of Prisons, “Federal Prison System FY 2017 Performance Budget,” available at <https://www.justice.gov/jmd/file/821381/download> (last visited April 9, 2018).+(last+visited+April+9,+2018).>Google Scholar

Joseph, A., “One State Takes a Novel Approach to Opioid Addiction: Access to Treatment for all Inmates,” STAT News, August 3, 2017, available at <https://www.statnews.com/2017/08/03/opioid-treatment-prisons/> (last visited April 9, 2018).+(last+visited+April+9,+2018).>Google Scholar

Office of Governor Gina Raimondo, M., “Raimondo Signs Ambitious Package of Bills Aimed at Preventing Overdoses and Saving Lives,” (July 12, 2016), available at <http://www.ri.gov/press/view/28044> (last visited April 9, 2018).+(last+visited+April+9,+2018).>Google Scholar

Anderson, P., Pina, A., and Bogdan, J., “Raimondo’s Midterm Grades: Campaign Promises During her first 2 Years as Governor,” The Providence Journal, February 10, 2017, available at <http://www.providencejournal.com/news/20170210/raimondos-midterm-grades-campaign-promises-during-herfirst-2-years-as-governor> (last visited April 9, 2018).+(last+visited+April+9,+2018).>Google Scholar

Office of Governor Gina Raimondo, M., “Raimondo Moves to Tackle Opioid Crisis, Appoints Task Force,” August 4, 2015, available at <http://www.ri.gov/press/view/25501> (last visited April 9, 2018).+(last+visited+April+9,+2018).>Google Scholar

Governor’s Overdose Prevention and Intervention Task Force, “Rhode Island’s Strategic Plan on Addiction and Overdose: Four Strategies to Alter the Course of an Epidemic,” November 4, 2015, available at <http://www.health.ri.gov/news/temp/RhodeIslandsStrategicPlanOnAddictionAndOverdose.pdf> (last visited April 9, 2018).+(last+visited+April+9,+2018).>Google Scholar

Centers for Disease Control and Prevention, National Center for Health Statistics. Underlying Cause of Death 1999-2013 on CDC WONDER Online Database, released 2015, available at <http://wonder.cdc.gov/ucd-icd10.html> (last visited April 9, 2018); SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013, available at <http://www.samhsa.gov/data/sites/default/files/NSDUHStateEst2012-2013-p1/Tables/NSDUHsaePercents2013.pdf on Oct 14, 2017> (last visited April 9, 2018).+(last+visited+April+9,+2018);+SAMHSA,+Center+for+Behavioral+Health+Statistics+and+Quality,+National+Survey+on+Drug+Use+and+Health,+2012+and+2013,+available+at++(last+visited+April+9,+2018).>Google Scholar

Raimondo, G.M., “Governor’s Overdose Prevention and Intervention Task Force,” Executive Order 15-14 (August 4, 2015).Google Scholar

Office of Governor Raimondo, supra note 189.Google Scholar

Governor’s Overdose Prevention and Intervention Task Force, supra note 190.Google Scholar

G.M. Raimondo, supra note 192.Google Scholar

Governor’s Overdose Prevention and Intervention Task Force, supra note 190.Google Scholar

Id.Google Scholar

Id.Google Scholar

Id.Google Scholar

Office of Governor Raimondo, supra note 189.Google Scholar

State of Rhode Island Office of Management and Budget, FY 2017 Interactive Budget, available at <http://www.omb.ri.gov/budget/prioryear/operating/2017.php> (last visited April 9, 2018).+(last+visited+April+9,+2018).>Google Scholar

Joseph, supra note 186.Google Scholar

Residential Substance Abuse Treatment (RSAT), “Prison/Jail Medication Assisted Treatment Manual,” available at <http://www.rsat-tta.com/Files/RSAT_Prison_Med_Treat_FINAL.pdf> (last visited April 9, 2018).+(last+visited+April+9,+2018).>Google Scholar

Id.Google Scholar

Id.Google Scholar

RSAT, “Medication-Assisted Treatment for Justice-Involved Populations: Profiles,” available at <http://www.rsat-tta.com/Files/MAT-for-Justice-Involved-Populations---just-profiles.docx> (last visited April 9, 2018).+(last+visited+April+9,+2018).>Google Scholar

Id.Google Scholar

Kaeble, D., Glaze, L., Tsoutis, A., and Minton, T., “Correctional Populations in the United States, 2014,” Bureau of Justice Statistics, December 29, 2015, available at <https://www.bjs.gov/index.cfm?ty=pbdetail&iid=5519> (last visited April 9, 2018).+(last+visited+April+9,+2018).>Google Scholar

Substance Abuse and Mental Health Services Administration, “Buprenorphine,” available at <https://www.samhsa.gov/medication-assisted-treatment/treatment/buprenorphine> (last visited April 9, 2018).+(last+visited+April+9,+2018).>Google Scholar

Author conversation with Connecticut DOC.Google Scholar

Id.Google Scholar

, supra note 203.Google Scholar

Author conversation, supra note 210.Google Scholar

Id.Google Scholar

Joseph, supra note 186.Google Scholar

Rhode Island Department of Corrections, “Facilities,” available at <http://www.doc.ri.gov/institutions/facilities/index.php> (last visited April 9, 2018).+(last+visited+April+9,+2018).>Google Scholar

Rhode Island Department of Corrections, “Budget Projections for MAT program,” January 2016.Google Scholar

Id.Google Scholar

T. Greene et al., supra note 11, at E1.Google Scholar

Id.Google Scholar

See e.g., Legal Action Center, “Legality of Denying Access to Medication Assisted Treatment in the Criminal Justice System,” (2011): 1-19, at 6-17, available at <https://lac.org/wp-content/uploads/2014/12/MAT_Report_FINAL_12-1-2011.pdf> (last visited April 9, 2018).+(last+visited+April+9,+2018).>Google Scholar